Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel bivalent neoantigen vaccine based on mRNA-loaded lipid nanoparticles eradicates hepatocellular carcinoma in mice.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Targeted Intracellular Delivery of Amino Acids to Trophoblast Cells Reveals Proteomic Signatures of Cellular Utilisation.

Biomolecules·2026
Same author

Hyperlipidemia promotes neutrophil extracellular trap-mediated osteonecrosis of the femoral head following methylprednisolone pulse in lupus mice.

Immunobiology·2026
Same author

Lipid nanoparticles containing zwitterionic lipids versatilely enhance the efficiency of mRNA delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Mitochondria-targeted coenzyme Q<sub>10</sub> nanocarriers evaluated by particle size and lipid composition alleviate early acetaminophen-induced liver injury.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Examining the Impact of Storage Conditions on the Stability of a Liquid Formulation of mRNA-Loaded Lipid Nanoparticles.

Pharmaceutics·2025

Related Experiment Video

Updated: Aug 13, 2025

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

24.0K

Development of a Mitochondrial Targeting Lipid Nanoparticle Encapsulating Berberine.

Ikuma Hori1, Hideyoshi Harashima1, Yuma Yamada1

  • 1Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.

International Journal of Molecular Sciences
|January 21, 2023
PubMed
Summary

Researchers developed a novel "MITO-Porter" lipid nanoparticle to deliver berberine (BBR) directly to mitochondria. This enhanced delivery improved cellular energy production and mitochondrial function, offering a promising strategy for neurodegenerative diseases.

Keywords:
lipid nanoparticlemitochondriamitochondrial deliveryneuroblastoma

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K

Related Experiment Videos

Last Updated: Aug 13, 2025

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

24.0K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Pharmacology

Background:

  • Mitochondria are crucial for neuronal energy production, making them therapeutic targets for neurodegenerative diseases.
  • Berberine (BBR) exhibits potential for neurodegenerative diseases due to its effects on mitochondrial metabolism.
  • Efficient delivery of BBR to mitochondria remains a challenge.

Purpose of the Study:

  • To develop a novel mitochondrial drug delivery system for Berberine (BBR).
  • To evaluate the efficacy of BBR delivered via a "MITO-Porter" lipid nanoparticle (LNP) in Neuro2a cells.
  • To investigate the impact of enhanced mitochondrial BBR delivery on cellular metabolism and mitochondrial function.

Main Methods:

  • Preparation of a lipid nanoparticle (LNP) system, termed "MITO-Porter", encapsulating Berberine (BBR).
  • Treatment of Neuro2a cells with MITO-Porter (BBR) and naked BBR.
  • Quantification of BBR accumulation in mitochondria.
  • Measurement of ATP production levels.
  • Assessment of mitochondrial ubiquitin ligase (MITOL) expression.

Main Results:

  • MITO-Porter (BBR) significantly increased BBR accumulation within mitochondria compared to naked BBR.
  • Treatment with MITO-Porter (BBR) led to enhanced ATP production in Neuro2a cells.
  • MITO-Porter (BBR) treatment increased the expression of mitochondrial ubiquitin ligase (MITOL), indicating improved mitochondrial quality control.

Conclusions:

  • Enhanced mitochondrial delivery of BBR via the MITO-Porter system potentiates its pharmacological effects.
  • This LNP-based delivery approach is crucial for regulating mitochondrial metabolic mechanisms in nerve cells.
  • The MITO-Porter system shows significant potential for therapeutic applications in neurodegenerative diseases.